These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2017-002565-22 Phase I/II Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer 2023-08-22 not-yet-due
Exempt 2019-003300-12 A Phase I/II Trial Investigating LOAd703 in Combination with Atezolizumab in Malignant Melanoma 2023-07-18 not-yet-due